women are to be denied a revolutionary new drug for breast cancer on the nhs -- the eighth such treatment to be turned down in three years .
the rationing watchdog will confirm today that it will block routine use of the drug -- which can extend life by more than six months -- for those with the most aggressive form of the disease .
kadcyla is the first medicine designed to attack cancer cells while dramatically reducing side-effects such as hair loss .
the nhs was offered a discount scheme by manufacturers roche , but nice wanted the price cut by 60 per cent .